Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0026764 (multiple myeloma)
 36,148 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Monoclonal antibodies can be produced in large amounts, are homogenous and can be highly purified. A specific monoclonal antibody against glandular kallikrein could be very useful in studies of the kallikrein-kinin system, both in vivo and in vitro. Two monoclonal antibodies against rat glandular kallikrein (rgKK) were produced by immunized mouse spleen and lymph node fusion with myeloma Ag8.653. Both antibodies, named 2E9.8 and 2E9.9, bound active 125I-kallikrein and phenylmethylsulfonyl fluoride (PMSF)-inactivated 125I-kallikrein. A radioimmunoassay (RIA) was developed with each of the antibodies using rabbit anti-mouse gamma globulin to separate bound from free 125I-rgKK. The standard curve (range 10-1000 ng/tube) was curved even when subjected to logit-log transformation. Using 3% polyethylene glycol (PEG) to assist separation of bound from free, the standard curve became straight for 2E9.8 and the RIA was more sensitive, with a binding range of 0.35-2.4 ng/tube. Both antibodies were specific for rgKK since they had negligible cross-reaction with purified proteases from the submandibular gland of the rat (tonin, esterases B and E). They did not cross-react with mouse nerve growth factor, epidermal growth factor, nor with pig pancreatic kallikrein. Antibody 2E9.9 did appear to bind some human kallikrein when tested with high concentrations of this enzyme, while 2E9.8 did not. When preincubated with purified rgKK, both antibodies prevented the enzyme from releasing kinins from semi-purified dog kininogen and from cleaving [3H]-L-arginine methyl ester (3H-TAME). These results suggested that both antibodies bind an epitope near to, and maybe including, the active site of the enzyme. Monoclonal antibody 2E9.8 appears to be specific for rgKK, can be used in a sensitive RIA, and is capable of inhibiting the enzymatic activity of kallikrein. It should prove to be useful in vivo for examining the role of kallikrein in physiological processes.
 ...
PMID:Characterization of monoclonal antibodies against rat glandular kallikrein. 363 49

Monoclonal antibody (MAb) was obtained to rat plasma kallikrein after immunization of BALB/c mice with the purified enzyme. Spleen cells from immunized mice were fused to P-3 mouse myeloma cells. Four antibody secreting hybridomas were identified by enzyme-linked immunosorbant assay (ELISA) for production of antibody to rat plasma kallikrein. One hybrid was cloned by limiting dilution and expanded as ascites tumor by injection of 5 X 10(6) cells into the peritoneal cavity of male BALB/c mice primed with 2,6,10,14-tetramethylpentadecane. Antibodies at a dilution as great as 1:20,000 were detected in ascites fluid and sera of immunized animals. The lower limit of detection of kallikrein was 0.1 microgram/ml. Secreted antibodies bound specifically to rat and human plasma kallikrein, but did not show any immunological interaction with human urinary or porcine pancreatic kallikrein. The MAb provides the necessary component for an enzyme-linked plasma kallikrein immunoassay.
 ...
PMID:Monoclonal antibody to rat plasma kallikrein. 656 1